Description
QuinRocin Injection
QuinRocin Injection is the latest antibacterial Flouroquinolone (Quinolone Carboxylic acid) indicated for exclusive use in Veterinary Medicine.
Recommended for:
Cattle, Buffalo, Sheep, Goat, Camel, Pigs and Poultry.
Benefits:
QuinRocin Injection covers all major bacterial infections of Gastrointestinal, Respiratory and Urino-genital systems.
QuinRocin Injection has a very broad antibactretial spectrum with very low MIC values covering Gram Positive,
Gram Negative and other bacterial infections like Mycoplasma, Chlamydia etc.
QuinRocin Injection penetrates effectively inside the body tissues thereby, covering both intercellular and intracellular infections.
QuinRocin Injection has unique mode of bactericidal action which does not allow plasmid mediated drug resistance to develop in bacteria.
QuinRocin Injection has a very convenient dosage schedule of 24 hours interval.
QuinRocin Injection has no side effects as it is non allergic, non mutagenic, non embryotoxic and completely safe for
cardiovascular and central nervous systems, and in pregnant animals.
Indications – Livestock:
Broncho pneumonia and other respiratory tract infections.
Contagious bovine and Caprine Pleuropneumonia (Mycoplasma spp).
Gastro enteritis, Calf scours.
Mastitis, Metritis, Pyometra.
Skin and soft tissue infections, ear injections.
Secondary bacterial infections notably those caused by E.coli, Salmonella Spp. Pseudomonas, Streptococcus,
Staphylococcus, B.bronchiseptica, Klebsiella etc.
Composition:
Each ml contains:
Enrofloxacin : 100 mg.
Methylparaben I.P. : 0.10% w/v
Propylparaben I.P. : 0.02% w/v
(As preservatives)
Dosage:
One ml of QuinRocin Injection per 20 kg body weight of the animal
(i.e, 5 mg per kg body weight)
Recommended dose range is 2.5 – 5 mg per kg body weight. Repeat the dose at 24 hrs interval for 3-5 days or as prescribed by the Registered Veterinary medical Practitioner.
Administration:
By Intramuscular or Intravenous injection.
Presentation:
Vial of 15 ml and 50 ml
Reviews
There are no reviews yet.